Literature DB >> 2617653

Towards a filariasis-free community: evaluation of filariasis control over an eleven year period in Flores, Indonesia.

F Partono1, R M Maizels.   

Abstract

A population of 202 residents in an area endemic for Brugia timori lymphatic filariasis was treated in a diethylcarbamazine control programme commencing in 1977. All individuals were treated twice with diethylcarbamazine on a mass basis with additional selected treatment for cases with manifestations of infection. Clinical features of lymphatic filariasis were recorded annually until 1982, and the population re-assessed in 1988, six years after the completion of chemotherapy. Microfilarial counts were made on each occasion, and circulating filarial antigen levels measured for 1982 and 1988. The results showed a dramatic and sustained reduction in the rate of elephantiasis and adenolymphangitic disease, and of circulating antigenaemia, and the prevalence of microfilaraemia was reduced to zero by the end of the study.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2617653     DOI: 10.1016/0035-9203(89)90343-x

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  10 in total

1.  A longitudinal analysis of the effect of mass drug administration on acute inflammatory episodes and disease progression in lymphedema patients in Leogane, Haiti.

Authors:  Brittany A Eddy; Anna J Blackstock; John M Williamson; David G Addiss; Thomas G Streit; Valery M Beau de Rochars; Leanne M Fox
Journal:  Am J Trop Med Hyg       Date:  2013-11-11       Impact factor: 2.345

2.  The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007).

Authors:  Brian K Chu; Pamela J Hooper; Mark H Bradley; Deborah A McFarland; Eric A Ottesen
Journal:  PLoS Negl Trop Dis       Date:  2010-06-01

3.  Feasibility and effectiveness of basic lymphedema management in Leogane, Haiti, an area endemic for bancroftian filariasis.

Authors:  David G Addiss; Jacky Louis-Charles; Jacquelin Roberts; Frederic Leconte; Joyanna M Wendt; Marie Denise Milord; Patrick J Lammie; Gerusa Dreyer
Journal:  PLoS Negl Trop Dis       Date:  2010-04-20

4.  Impact of two rounds of mass drug administration using diethylcarbamazine combined with albendazole on the prevalence of Brugia timori and of intestinal helminths on Alor Island, Indonesia.

Authors:  Tim Oqueka; Taniawati Supali; Is Suhariah Ismid; Paul Rückert; Mark Bradley; Peter Fischer
Journal:  Filaria J       Date:  2005-07-13

5.  Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: a review of the scientific literature.

Authors:  David G Addiss; Molly A Brady
Journal:  Filaria J       Date:  2007-02-15

6.  Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease.

Authors:  K D Ramaiah; Eric A Ottesen
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

Review 7.  A systematic review of factors that shape implementation of mass drug administration for lymphatic filariasis in sub-Saharan Africa.

Authors:  Adam Silumbwe; Joseph Mumba Zulu; Hikabasa Halwindi; Choolwe Jacobs; Jessy Zgambo; Rosalia Dambe; Mumbi Chola; Gershom Chongwe; Charles Michelo
Journal:  BMC Public Health       Date:  2017-05-22       Impact factor: 3.295

8.  Comparison of the Impact of Annual and Semiannual Mass Drug Administration on Lymphatic Filariasis Prevalence in Flores Island, Indonesia.

Authors:  Taniawati Supali; Yenny Djuardi; Adriani Lomiga; Sovie Nur Linda; Elisa Iskandar; Charles W Goss; John Philip Miller; Gary J Weil; Peter U Fischer
Journal:  Am J Trop Med Hyg       Date:  2019-02       Impact factor: 3.707

Review 9.  A review of factors that influence individual compliance with mass drug administration for elimination of lymphatic filariasis.

Authors:  Alison Krentel; Peter U Fischer; Gary J Weil
Journal:  PLoS Negl Trop Dis       Date:  2013-11-21

10.  The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000-2014).

Authors:  Hugo C Turner; Alison A Bettis; Brian K Chu; Deborah A McFarland; Pamela J Hooper; Eric A Ottesen; Mark H Bradley
Journal:  Infect Dis Poverty       Date:  2016-05-24       Impact factor: 4.520

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.